Andrew Sweet
73 posts

Andrew Sweet
@andrewsweet
Investor, entrepreneur, curious Focused on the application of AI/ML in the mundane
Katılım Eylül 2012
400 Takip Edilen16 Takipçiler

Love this. I have a 30 + year investing career that fits this exact mindset, and I am still exasperated when people look at me like a donkey when I say I am not sector focused.
In my personal journey, I have also experienced this on a regional vector - meaning translating themes from one region to another, etc.
English

I’ve always believed that opportunities live between fields of expertise.
If something fits neatly in a bucket, it’s probably already priced in.
This has been my investment philosophy, a metaphor for my career and where I like to invest.
Am I Silicon Valley or Wall Street, a founder, operator or investor? My answer has always been the same: Yes.

English
Andrew Sweet retweetledi
Andrew Sweet retweetledi

Andrew Sweet retweetledi

ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders Urges Shareholders to Vote AGAINST All Director Nominees Amid Governance Failures and Calls for Independent Oversight of Annual Meeting Vote GREENWICH, Conn. & CHESTERFIELD, Mo. – (BUSINESS WIRE) -- ASL Strategic Value Fund, LP (together with its affiliates, “ASL Strategic Value Fund” or “we”), a significant shareholder of Avadel Pharmaceuticals plc (NASDAQ: AVDL) (“Avadel” or the “Company”), today issued an open letter calling on Avadel’s shareholders to vote AGAINST all of the Company’s director nominees up for election at the 2025 annual general meeting of shareholders scheduled for July 29, 2025 (the “Annual Meeting”). The full text of the letter is as follows: Dear Valued Avadel Shareholder: As you prepare to vote your shares at the upcoming Annual Meeting scheduled to be held on July 29, 2025, we urge you to consider the following additional critically important information and to vote AGAINST all of the Company’s director nominees at the Annual Meeting. If you have already voted, you can change your vote to AGAINST prior to the Annual Meeting by submitting a proxy with a later date (but the proxy must be received by the Company by 10:00 a.m. (Irish Standard Time) on July 28, 2025). #AVDL #avadel
English
Andrew Sweet retweetledi

@2mile I am trying to reach you. Please respond! thank you for your attention to this matter
English
Andrew Sweet retweetledi

RT @AslValue: Mr. Geoff Glass Chairman, Board of Directors Avadel Pharmaceuticals Plc 16640 Chesterfield Grove Road, Suite 200 Chesterfield…
English
Andrew Sweet retweetledi
Andrew Sweet retweetledi
Andrew Sweet retweetledi
Andrew Sweet retweetledi

"The underlying challenge for Uber and Lyft is simple. Namely, if Empower is earning drivers more money and saving riders more money, it may greatly threaten its competitors' business models."
-@TomRtweets
trib.al/fcVNpmS
English
Andrew Sweet retweetledi
Andrew Sweet retweetledi

@matthewroche I remember this in high school era...probably 1986 or '87. Fantastic
English













